|
Molecular analysis and therapeutic targeting of PI3K signaling in thyroid cancer
|
2R01CA128943-06A1
|
$175,062
|
$175,062
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
5R01CA167839-03
|
$172,015
|
$172,015
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Molecular analysis and therapeutic targeting of PI3K signaling in thyroid cancer
|
6R01CA128943-07
|
$221,563
|
$221,563
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
6R01CA167839-04
|
$174,510
|
$174,510
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-43S1
|
$199,871
|
$5,996
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-42
|
|
$0
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
6P30CA013330-43
|
$3,696,138
|
$110,884
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Development of breakthrough intra-operative detector and imaging system for parat
|
5R42CA192243-03
|
$544,697
|
$364,947
|
MAHADEVAN-JANSEN, ANITA
|
ANASYS INSTRUMENTS CORPORATION
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cance
|
1R01CA194473-01
|
$386,514
|
$386,514
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$63,103
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
$2,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
$3,661
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
BRAFV600E and VEGFR2 synergize to trigger papillary thyroid cancer progression
|
5R01CA181183-02
|
$361,050
|
$361,050
|
NUCERA, CARMELO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Cancer Center Support Grant
|
2P30CA014236-41
|
$5,661,203
|
$56,612
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-41S1
|
$56,234
|
$562
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Single cell analysis of intratumoral heterogeneity in parathyroid neoplasia
|
1R21CA192004-01
|
$195,180
|
$195,180
|
KOH, JAMES
|
DUKE UNIVERSITY
|
|
Drosophila models of Ret fusions in Papillary Thyroid Carcinoma
|
5F31CA189794-02
|
$35,722
|
$35,722
|
LEVINSON, SARAH
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Regional Oncology Research Center
|
3P30CA006973-52S1
|
$31,250
|
$625
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S2
|
$125,000
|
$2,500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S3
|
$185,800
|
$3,716
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-52
|
$6,995,267
|
$139,905
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
TERT Promoter Mutations in Thyroid Cancer
|
1R01CA189224-01A1
|
$362,066
|
$362,066
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Genetic & Epigenetic Events in Papillary Thyroid Cancer
|
5R01CA113507-08
|
$276,273
|
$276,273
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
$58,986
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Optimization of Treatment of Papillary Thyroid Cancer: A Risk-tailored Approach
|
5K07CA177900-02
|
$142,352
|
$142,352
|
LUBITZ, CARRIE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The Role of BRAF Mutation in Thyroid Cancer Invasion
|
5R01CA149738-05
|
$319,757
|
$319,757
|
PARANGI, SAREH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Two-Photon Fluorescence Lifetime Microscopy for Breast and Thyroid Cancer Margin
|
5F32CA183400-02
|
$54,194
|
$27,097
|
GIACOMELLI, MICHAEL
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Research Management and Support
|
RMS ES 2015
|
$348,215,937
|
$108,000
|
Unknown, Unknown
|
National Cancer Institute
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$430,051
|
$21,503
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 - 10527
|
$854,646
|
$85,465
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Corn Farming Study
|
ZIA CP010119 - 02075
|
$56,585
|
$2,829
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Risk factors for thyroid cancer in the NCI cohorts
|
ZIA CP010219 - 10447
|
$47,865
|
$47,865
|
Berrington, Amy
|
DCEG (NCI)
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$521,597
|
$417,278
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,530,484
|
$726,524
|
Custer, Mary
|
CCR (NCI)
|
|
Breast and other cancers following x-rays for scoliosis
|
ZIA CP010222 - 04150
|
$27,969
|
$280
|
Doody, Michele
|
DCEG (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,389,288
|
$131,679
|
Gulley, James
|
CCR (NCI)
|
|
NICHD_NCI_ Health Effects of in Utero Exposure to I-131 in Chernobyl Fallout
|
ZIA CP010132 - 10661
|
$41,298
|
$41,298
|
Hatch, Maureen
|
DCEG (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,735,022
|
$86,751
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Ambient dioxin exposure and cancer risk in women (IWHS and AHS)
|
ZIA CP010125 - 10712
|
$100,308
|
$20,062
|
Jones, Rena
|
DCEG (NCI)
|
|
Genomic and genetic studies of endocrine cancers
|
ZIA BC 011275
|
$413,513
|
$206,757
|
Kebebew, Electron
|
CCR (NCI)
|
|
Therapeutic targets and novel anticancer agents for endocrine cancers
|
ZIA BC 011286
|
$689,189
|
$344,595
|
Kebebew, Electron
|
CCR (NCI)
|
|
Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC)
|
ZIA BC 011287
|
$385,946
|
$385,946
|
Kebebew, Electron
|
CCR (NCI)
|
|
EOB Clinical Core
|
ZID BC 011534
|
$441,081
|
$110,270
|
Kebebew, Electron
|
CCR (NCI)
|
|
EOB Clinical and Research Fellowship Training Program
|
ZIE BC 011656
|
$827,027
|
$206,757
|
Kebebew, Electron
|
CCR (NCI)
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$110,957
|
$55,479
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
Thyroid Stem/Progenitor Cells
|
ZIA BC 005522
|
$416,092
|
$416,092
|
Kimura, Shioko
|
CCR (NCI)
|
|
Cancer registry-linkage studies of thyroid cancer
|
ZIA CP010219 - 10682
|
$18,110
|
$18,110
|
Kitahara, Cari
|
DCEG (NCI)
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 - 04180
|
$1,119,312
|
$167,897
|
Linet, Martha
|
DCEG (NCI)
|
|
Dosimetry for Nuclear Medicine Technologists
|
ZIA CP010133 - 10558
|
$113,182
|
$22,636
|
Linet, Martha
|
DCEG (NCI)
|
|
Chornobyl Thyroid Study (Belarus)
|
ZIA CP010132 - 04019
|
$334,783
|
$334,783
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
Total relevant funding to Thyroid for this search: $25,154,614
|